This in vitro study reports on the enhanced release of the hydrophobic drug itraconazole from the ordered mesoporous SBA-15 silica material and on the existence of a critical mesopore diameter for enhancing release.status: publishe
The effectiveness of oral drug administration is related to the solubility of a drug in the gastroin...
Not AvailableThe present study is focused on functionalisation of mesoporous silica (or SBA-15) to c...
Objective: The purpose of the study was to develop the multiple unit non-effervescent gastroretentiv...
The ordered mesoporous silica material SBA-15 was loaded with the model drugs itraconazole and ibupr...
The release of poorly soluble drugs from mesoporous silicates is often associated with the generatio...
This study aims to evaluate the in vivo performance of ordered mesoporous silica (OMS) as a carrier ...
The mesoporous SBA-15 silica with uniform hexagonal pore, narrow pore size distribution and tuneable...
Ordered mesoporous silica (OMS) materials are considered a promising drug delivery system for the di...
The release of the hydrophobic cancer drug dasatinib from two mesoporous silica materials as drug de...
In this study, the potential of wet granulation of ordered mesoporous silica (OMS) material was eval...
The interest in mesoporous silica as a drug release enhancer for poorly soluble drugs is one of the ...
The majority of innovative drug candidates are poorly water soluble and exhibit basic properties. Th...
In this paper, we present the release of baicalin from hexagonal periodic mesoporous silica SBA-15 a...
The purpose of this study was to improve our understanding of the molecular organization of hydropho...
Poor aqueous solubility is one of the greatest barriers for new drug candidates to enter toxicology ...
The effectiveness of oral drug administration is related to the solubility of a drug in the gastroin...
Not AvailableThe present study is focused on functionalisation of mesoporous silica (or SBA-15) to c...
Objective: The purpose of the study was to develop the multiple unit non-effervescent gastroretentiv...
The ordered mesoporous silica material SBA-15 was loaded with the model drugs itraconazole and ibupr...
The release of poorly soluble drugs from mesoporous silicates is often associated with the generatio...
This study aims to evaluate the in vivo performance of ordered mesoporous silica (OMS) as a carrier ...
The mesoporous SBA-15 silica with uniform hexagonal pore, narrow pore size distribution and tuneable...
Ordered mesoporous silica (OMS) materials are considered a promising drug delivery system for the di...
The release of the hydrophobic cancer drug dasatinib from two mesoporous silica materials as drug de...
In this study, the potential of wet granulation of ordered mesoporous silica (OMS) material was eval...
The interest in mesoporous silica as a drug release enhancer for poorly soluble drugs is one of the ...
The majority of innovative drug candidates are poorly water soluble and exhibit basic properties. Th...
In this paper, we present the release of baicalin from hexagonal periodic mesoporous silica SBA-15 a...
The purpose of this study was to improve our understanding of the molecular organization of hydropho...
Poor aqueous solubility is one of the greatest barriers for new drug candidates to enter toxicology ...
The effectiveness of oral drug administration is related to the solubility of a drug in the gastroin...
Not AvailableThe present study is focused on functionalisation of mesoporous silica (or SBA-15) to c...
Objective: The purpose of the study was to develop the multiple unit non-effervescent gastroretentiv...